Breastfeeding Withdrawn Phase 3 Trials for Emtricitabine (DB00879)

IndicationStatusPhase
DBCOND0031330 (Breastfeeding)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00936195Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 TrialPrevention